logo
Apartments for Rent in a Former Office, but You Have to Live in Midtown

Apartments for Rent in a Former Office, but You Have to Live in Midtown

New York Times28-04-2025

For many New Yorkers, Midtown Manhattan, with its gleaming skyscrapers and busy transportation hubs, lacks an element of cool and cachet that its more culturally vibrant neighbors have. Hordes of office workers, commuters and tourists typically flood the area, leaving it feeling anything but residential.
What Midtown does have, though, is a glut of underutilized office buildings. Two in particular brought Nathan Berman, chief executive of Metro Loft Management, to the area: the hulking buildings of Pfizer's former headquarters on East 42nd Street near Grand Central Terminal. Metro Loft, along with David Werner Real Estate, is converting the buildings into about 1,600 rental apartments.
Once completed, the project would be the largest office-to-apartment conversion nationwide, Mr. Berman said. The first tenants are expected to move in at the end of next year.
The developers also recently bought an office building around the corner from the Pfizer site to create roughly 450 residences, 25 percent of which will be affordable housing.
'We go where there is opportunity to convert what we believe to be undervalued assets, and we can do that anywhere in Manhattan,' Mr. Berman added. 'Right now, Midtown seems to be presenting the most opportunities for us.'
Mr. Berman has spent over two decades converting office buildings in the financial district, but the Pfizer project is his first in Midtown. He believes that future tenants, whom he calls 'active younger professionals,' will forgo more traditional neighborhoods like Greenwich Village, Chelsea or the Upper East Side, with their charming cafes and green spaces, for splashy building amenities like a gym, a rooftop pool, lounges, co-working spaces, and a washer and dryer in each apartment.
'No one even needs a grocery store anymore, since everything gets delivered,' Mr. Berman said.
In addition, he said, as more companies order employees back to their desks, he hopes more people will want to live closer to the office, even if they have to be on site only part of the week. People 'want to walk or bike or even scooter to their offices,' he said.
Arpit Gupta, an associate professor of finance at New York University's Stern School of Business, said the proximity to thousands of workplaces was one of Midtown's selling points. And once people move in, it'll help the neighborhood: More tenants will eventually attract 'the construction of retail, food and beverage industries, which serve to attract other renters in a positive cycle,' she said.
Metro Loft was one of the first to transform moribund office buildings in the financial district into apartments. Mr. Berman's first big project downtown, at 17 John Street, was converted in 1998. Since then, he has converted 15 buildings in the financial district, with four more in development and others in the pipeline.
In cities across the country, more office buildings have been turned into housing, as officials clamor to solve for the mismatch between a surfeit of outdated office buildings and a lack of housing.
This year, nearly 71,000 residences have either been approved, remain under construction or are in the planning phase, which is more than triple the number from three years ago, according to a February report from RentCafe. New York, which is the country's largest office market, has over 8,300 offices set to be converted into apartments this year.
In other cities, developers often opt for areas with a mix of commercial and residential properties. Michael Pestronk, the chief executive of the development company Post Brothers, prefers converting office buildings into apartments in neighborhoods already replete with housing, he said. But his Philadelphia-based firm — which, according to its website, has worked on more than 30 properties — recently started work on converting buildings in Washington, D.C.
'We've certainly done developments in tertiary neighborhoods, but with the number of opportunities we're seeing today, we feel like we don't need to be in pioneering locations,' Mr. Pestronk said, referring to areas not considered traditionally residential. 'Instead, we're focused on main locations that are very obvious in terms of the demand.'
Many developers have been keen to convert office buildings as more properties sell at a discount, many of them in central business districts that for years have suffered from empty buildings and streets.
'From 2012 to 2019, these buildings that we're converting were trading — even if they were basically obsolete — for $400 to $500 per square foot, and now they're $100 to $200 a square foot,' Mr. Pestronk said.
Adapting older commercial properties can also be less costly than building new housing. Research from CBRE, a real estate firm, estimates the cost of conversion to be $100 to $500 or more per square foot, depending on the original layout. Those costs are still as much as 20 percent less than building something new because the edifice is retained, Mr. Pestronk said.
The biggest cost differential, he said, is from the time saved. Construction on a conversion can be completed as much as one year faster than building something from the ground up.
'The speed to market is worth almost as much as the savings from reusing the structure,' he added.
Commercial structures also have thicker floor slabs, built to accommodate heavy equipment, making them ideal for reducing noise in closer living arrangements.
But not all empty or outdated buildings can be converted. Estimates vary, but a Moody's Analytics study from 2023 of New York offices found that only 3 percent were suitable for transformation. A study for the Brookings Institution suggested that 9 to 11 percent of buildings nationwide could be converted, a statistic that translates into about 2,500 buildings.
The difficulty in turning office buildings into apartments is that they are laid out differently. Office buildings, for example, may not have windows that open or have too much space from wall to wall.
Buildings that are converted are usually gutted and reimagined. The old Pfizer buildings have floors that are roughly 200 feet deep, and Mr. Berman will have to divide the space to meet light and air regulations, such as the requirement that each apartment has a minimum distance between an operable window and building walls.
Mr. Berman has had experience doing this. Most recently, he did it at 25 Water Street in New York's financial district, which had a depth almost as large as Pfizer's old offices. The solution: Create two atriums so that more windows can be added to apartments. The plan is to do the same at the Pfizer buildings.
Then there are complex zoning restrictions and higher interest rates, and even experienced developers like Mr. Berman could run into unexpected expenses that put a project at risk. Not to mention potential tariffs, which are a wild card that will affect the price of materials needed for new construction as well as conversions.
Post Brothers recently faced foreclosure at one of its buildings in Washington, and Metro Loft encountered financial problems because of rising rates at two properties, even though both were more than 90 percent occupied.
'If you're highly leveraged and your rate doubles, it will put you in a tough situation,' a spokesperson for the firm said.
As for whether young people will happily move to the bustle of Midtown: If the past is any indication, it's possible. It happened in both the financial district and Hudson Yards, the mixed-use area on the western edge of Manhattan where Pfizer has relocated. Mr. Berman hopes to replicate the success in Midtown.
He said, 'Shaking and transforming buildings in the middle of what is an office area takes an empty office building off the market and brings in residential and that will invigorate an area.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

With gas, electric bills surging, NY pushes regulatory agency to get tough on utilities
With gas, electric bills surging, NY pushes regulatory agency to get tough on utilities

Yahoo

time8 hours ago

  • Yahoo

With gas, electric bills surging, NY pushes regulatory agency to get tough on utilities

The New York State Senate, responding to double-digit rate hike demands from gas and electric utilities, recently approved measures targeting the state agency that signs off on utility requests. One would add an eighth slot to New York's Public Service Commission board for a consumer advocate. And another would ban former utility employees from joining the commission for at least two years after leaving their employment. They're among a package of eight member bills Majority Leader Andrea Stewart-Cousins shepherded through the state Senate in recent weeks. 'This package flips the script — putting people over profits,' Stewart-Cousins said. 'Utilities are a lifeline, not a luxury. For too long, New Yorkers have been treated as cash cows by companies that answer to shareholders, not the people.' The Assembly is expected to consider the package ahead of the summer recess. At the end of February, about 1.2 million gas and electric customers were behind at least two months on their bills, a total of $1.8 billion in arrears. Consumer advocates have called it an energy affordability crisis. Gov. Kathy Hochul has responded by, among other things, urging the commission to reject a double-digit rate increase from Con Edison, the state's largest utility. Bills: Hudson Valley customers: What's contributing to your high gas, electric bills? 'Far too many New Yorkers feel like they are in the dark when it comes to their utility bills,' said Laurie Wheelock, the executive director of the Public Utility Law Project, which advocates for customers. 'The Senate's utility affordability package advances many reforms that promote transparency, empower ratepayers, and improve oversight of utility practices.' Other measures passed in recent weeks would: Force utilities to give consumers refunds if the utility has exceeded their agreed-upon profit limits. Alert families to surging bills by telling them when usage is exceeding their threshold. Have the PSC consider non-economic damages like stress caused by a power outage when determining fines for utilities accused of misconduct. Extend to 14 months the review period for rate hikes, allowing more time for challenges. ConEd, whose territory includes Westchester County and New York City, is seeking increases of $14 for residential electric customers and around $46 for gas customers, which would kick in next year. Pipes: Leaky gas pipes cost NY utilities billions a year. How it trickles down to your gas bill Utilities across the state say they need the extra revenue to replace outdated infrastructure and for climate-related upgrades to guard against high-intensity storms that are occurring greater frequency. Thomas C. Zambito covers energy, transportation and economic growth for the USA Today Network's New York State team. He's won dozens of state and national writing awards from the Associated Press, Investigative Reporters and Editors, the Deadline Club and others during a decades-long career that's included stops at the New York Daily News, The Star-Ledger of Newark and The Record of Hackensack. He can be reached at tzambito@ This article originally appeared on Rockland/Westchester Journal News: How NY is pushing state regulatory group to get tough on utilities

This FTSE 100 company is down 33% this year. Here's why I'm thinking of buying
This FTSE 100 company is down 33% this year. Here's why I'm thinking of buying

Yahoo

time10 hours ago

  • Yahoo

This FTSE 100 company is down 33% this year. Here's why I'm thinking of buying

Shares in FTSE 100 media giant WPP (LSE: WPP) soared to over 1,900p in 2017, but have since slumped to around 500p. We saw a brief recovery after the 2020 stock market crash. But WPP is the worst Footsie performer so far in 2025, losing a third of its value year to date. Hmm, maybe I should dust off my contrarian buy button. On 9 June the company announced the pending departure of CEO Mark Read, who took over from Sir Martin Sorrell in 2018. It seems he 'decided that the time is right for him to hand over to a new leader and the search for a successor is underway'. Does this sounds a bit sudden, and maybe not well prepared? I wonder if he'd have made the same decision had the company not just lost a $1.7bn Mars media deal? And if it hadn't also lost big contracts with Pfizer and Coca-Cola? Some sources are suggesting his days were numbered. But doesn't it mean we should be considering selling WPP shares? And that I might be mad to think of buying? We're currently still suffering from inflation and high interest rates. And we just heard that the UK economy shrank 0.3% in April. The US is in some turmoil too, with inflation fears rising on the back of President Trump's aggressive approach to international trade. This is surely a time when companies have higher priorities than marketing, advertising, and media spend. And that in turn must make short-term news a poor indicator of whether we should consider buying stocks in a sector like this. And isn't that when contrarian investors who see long-term attraction should think about jumping in and buying, while a stock is down? There's a forecast dividend yield of 7% at WPP, boosted by the fallen share price. Locking in that kind of return could be nicely profitable. But it depends on whether the dividend is likely to be sustained. Forecasts currently suggest it will be, at least until 2027. And that it should be solidly covered by earnings. Analysts also think earnings will grow in the next three years. But I wonder if they might be a bit out of date now and could scale back when they get their heads round the latest outlook? That's a danger. Most brokers have WPP as a Hold, despite setting a price target range of 520p to 740p — with the shares at 550p at the time of writing. It suggests their thoughts are dominated by uncertainty right now and they don't want to commit. WPP needs to respond to a changing business. And it's one in which artificial intelligence (AI) is likely to play an increasing part. Could that open competition to leaner and smarter AI-based operations? It's possible WPP could go the way of dinosaurs. But experience built up over decades should still count for a lot. And for those who see a profitable long-term future for this kind of business, WPP surely has to be one to consider for a potential (risky) recovery buy. The post This FTSE 100 company is down 33% this year. Here's why I'm thinking of buying appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Viking Therapeutics (VKTX) Rises on Expected Developments
Viking Therapeutics (VKTX) Rises on Expected Developments

Yahoo

time14 hours ago

  • Yahoo

Viking Therapeutics (VKTX) Rises on Expected Developments

We recently published a list of . In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other top-performing companies on Tuesday. Viking Therapeutics grew its share prices by 5.69 percent on Tuesday to finish at $29.14 apiece as investors loaded up positions while waiting for fresh catalysts from the series of global conferences that it is participating in this month. At present, investors are expecting updates and developments from the three-day 46th Annual Goldman Sachs Global Healthcare Conference in Florida on June 9 to 11. It is also set to participate in a one-on-one meeting at the Scotiabank Third Annual Healthcare Canadian Investor Day on June 17. In April this year, Viking Therapeutics, Inc. (NASDAQ:VKTX) soared following news that its competitor, Pfizer Inc., discontinued the development of its oral obesity medication, danuglipron, amid safety concerns. According to PFE, the decision came after a patient experienced a potential liver injury linked to the drug. A microbiologist in protective gear studying samples in a laboratory. The scrapped plans, however, spelled good news for Viking Therapeutics, Inc. (NASDAQ:VKTX), which is similarly underway with the development of an oral weight loss candidate called VK2735, with Pfizer Inc. now out of the competition. Overall, VKTX ranks 8th on our list of top-performing companies on Tuesday. While we acknowledge the potential of VKTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store